Assessment of Immunomarker Profiling in Bone Marrow Trephine Biopsy (BMTB) for Lymphoma Diagnosis: Efficacy of Immunomarker Profiling in Lymphoma Diagnosis

Mizna Arif; Samreen Hameed; Rafeeda Maab; Maimoona Iqbal; Hamna Annum; Noshin Mehdi

doi:10.54393/pjhs.v5i07.1916

Authors

Mizna Arif Department of Pathology, King Edward Medical University, Lahore, Pakistan
Samreen Hameed Department of Pathology, King Edward Medical University, Lahore, Pakistan
Rafeeda Maab Department of Pathology, King Edward Medical University, Lahore, Pakistan
Maimoona Iqbal Department of Pathology, King Edward Medical University, Lahore, Pakistan
Hamna Annum Department of Pathology, King Edward Medical University, Lahore, Pakistan
Noshin Mehdi Department of Pathology, King Edward Medical University, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i07.1916

Keywords:

Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Immunohistochemistry, Bone Marrow Trephine Biopsy, Immunomarker

Abstract

Lymphomas are characterized by clonal abnormality of the lymphatic system resulting in malignant neoplasms, classified into Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL). The immunophenotyping and genetic features of the lymphomas play a major role in its classification. Objective: To determine the immunohistochemical profiles for multiple types of Lymphoma by using the primary (CD30, CD20, CD3) and secondary (CD15, CD5, CD10, Ki67, BCL6,) panel of immunomarker. Methods: This cross-sectional study was done over a period of 1 year from 1st January 2023 to 31st December 2023. A consecutive sampling technique was used. Bone marrow aspiration, and trephine biopsy samples were taken from each patient. Immunohistochemical (IHC) profiling was done on Trephine biopsy to diagnose Lymphomas. Results: Out of 57 lymphoma cases, 41 were male and 16 were female patients. The most affected age group was 45-60 years. Among total cases, 43 (75.4%) were of NHL while only 14 (24.6%) cases were of HL. Among 43 cases of NHL, 38 (88.4%) were found of B-cell type while only 5 (11.6%) were of T-cell origin. CD30 (85.7%) was the most expressed immunomarker in HL while CD20 (92%), CD3 (60%), CD5 (47%), and Ki67 showed the highest positivity rate in NHL. IHC was found to be significant by statistical analysis (p-value < 0.05). Conclusion: In addition to morphological findings, another crucial step in lymphoma diagnosis is the selection of relevant immunomarkers after clinicopathological correlation with the patient. Therefore, based on our experience, we suggest the use of a limited, cost-effective immunomarker panel for optimal diagnosis of lymphomas and subtypes.

References

Ali M, Meena A, Bhopalwala F, Banseria N. Study of infiltration patterns of lymphomas in bone marrow trephine biopsy and immunohistochemical analysis in a tertiary care institute. International Journal of Health Sciences. 2022; 6(S9): 1327-34. doi: 10.53730/ijhs.v6nS9.12550. DOI: https://doi.org/10.53730/ijhs.v6nS9.12550

Shanmugasundaram S, Balan K, Arumugam D. Immunohistochemical profile and distribution of non-Hodgkin and Hodgkin lymphoma-An experience in a medical college hospital in Tamil Nadu. Indian Journal of Medical and Paediatric Oncology. 2020 Jul; 41(05): 695-701. doi: 10.4103/ijmpo.ijmpo_90_20. DOI: https://doi.org/10.4103/ijmpo.ijmpo_90_20

Basu D. Patterns of bone marrow infiltration in lymphomas-A retrospective descriptive analysis from a tertiary care centre in Southern India. IP Journal of Diagnostic Pathology and Oncology. 2022; 7(4): 223-228. doi: 10.18231/j.jdpo.2022.053. DOI: https://doi.org/10.18231/j.jdpo.2022.053

Chipidza FE, Kayembe MK, Nkele I, Efstathiou JA, Chabner BA, Abramson J et al. Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana. JCO Global Oncology. 2021 Dec; 7: 1620-32. doi: 10.1200/GO.21.00209. DOI: https://doi.org/10.1200/GO.21.00209

Derqaoui S, Boujida I, Marbouh O, Rouas L, Hessissen L, Lamalmi N. Non Hodgkin Lymphoma Among Children: Pathological Aspects and Diagnostic Challenges. Clinical Pathology. 2022 Apr; 15. doi: 10.1177/2632010X221090156. DOI: https://doi.org/10.1177/2632010X221090156

Dhaliwal A, Eller VF, Pu JJ. Immunocompetent Patient with Primary Bone Marrow Hodgkin Lymphoma. Journal of Medical Cases. 2022 Sep; 13(9): 427-431. doi: 10.14740/jmc3973. DOI: https://doi.org/10.14740/jmc3973

Gonçalves MD, de Oliveira CR, Sandes AF, Rodrigues CA, Novis Y, Viana PC et al. Core needle biopsy in lymphoma diagnosis: the diagnostic performance and the role of the multidisciplinary approach in the optimization of results. The American Journal of Surgical Pathology. 2023 Jan; 47(1): 111-23. doi: 10.1097/PAS.0000000000001991. DOI: https://doi.org/10.1097/PAS.0000000000001991

Kıvrak H, Yüksel S, Ateş C, Merter M, Kaygusuz G, Özcan M et al. Relevance of additional immunohistochemical markers in the Differential diagnosis of small B-Cell lymphomas: a case-control study. Turkish Journal of Hematology. 2022 Sep; 39(3): 178-187. doi: 10.4274/tjh.galenos.2021.2021.0349. DOI: https://doi.org/10.4274/tjh.galenos.2021.2021.0349

Oliveira LR, Hinojosa GC, Etchebehere RM. Reed-Sternberg and Hodgkin cells in bone marrow aspirate from a classical Hodgkin lymphoma patient. Hematology, Transfusion and Cell Therapy. 2022 Jun; 44(2): 301-2. doi: 10.1016/j.htct.2021.02.002. DOI: https://doi.org/10.1016/j.htct.2021.02.002

Vasudevan JA, Mary JR, Sukumaran R, Narayanan G. Primary Extranodal Lymphomas: A Five Year Retrospective Study from a Tertiary Care Cancer Centre, Kerala, India. Journal of Clinical and Diagnostic Research. 2022 May; Vol-16(5): EC23-EC26. doi: 10.7860/JCDR/2022/53164.16323. DOI: https://doi.org/10.7860/JCDR/2022/53164.16323

Vangala N, Paul TR, Uppin SG, Uppin MS, Sadashivudu G, Raju YS et al. Clinically Undetected Hodgkin Lymphoma Diagnosed Initially on Bone Marrow Biopsy: A Large Retrospective Observational Study from a Tertiary Care Center. Indian Journal of Medical and Paediatric Oncology. 2021 Dec; 42(06): 554-60. doi: 10.1055/s-0041-1740048. DOI: https://doi.org/10.1055/s-0041-1740048

Özdemir Ç, Yavaşoğlu F, Şenol Y, Şahin M, Köken T. A Comparison of Bone Marrow Flow Cytometry Findings and Bone Marrow Biopsy İmmunohistochemical Findings in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Methodological Study. Eskisehir Medical Journal. 2023 Mar; 4(1): 34-40. doi: 10.48176/esmj.2023.101. DOI: https://doi.org/10.48176/esmj.2023.101

Nadda R, Repaka R, Mallik N, Sahani AK. A prospective survey on trephine biopsy of bone and bone marrow: an experience with 274 Indian patients’ biopsies. European Journal of Medical Research. 2023 Jun; 28(1): 193. doi: 10.1186/s40001-023-01167-7. DOI: https://doi.org/10.1186/s40001-023-01167-7

Nair R, Arora N, Mallath MK. Epidemiology of non-Hodgkin's lymphoma in India. Oncology. 2016 Jul 28; 91(Suppl. 1): 18-25. doi: 10.1159/000447577. DOI: https://doi.org/10.1159/000447577

Roy A, Kar R, Basu D, Badhe BA. Spectrum of histopathologic diagnosis of lymph node biopsies: A descriptive study from a tertiary care center in South India over 5½ years. Indian Journal of Pathology and Microbiology. 2013 Apr; 56(2): 103-8. doi: 10.4103/0377-4929.118692. DOI: https://doi.org/10.4103/0377-4929.118692

Aschebrook-Kilfoy B, Caces DB, Ollberding NJ, Smith SM, Chiu BC. An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA. Leukemia & lymphoma. 2013 Aug; 54(8): 1677-83. doi: 10.3109/10428194.2012.760041. DOI: https://doi.org/10.3109/10428194.2012.760041

Mondal SK, Mandal PK, Roy SD, Chattopadhyay S, Roy S, Biswas PK. Malignant lymphoma in Eastern India: a retrospective analysis of 455 cases according to World Health Organisation classification. Journal of Cancer Research and Therapeutics. 2014 Apr; 10(2): 354-8. doi: 10.4103/0973-1482.136639. DOI: https://doi.org/10.4103/0973-1482.136639

Padhi S, Paul TR, Challa S, Prayaga AK, Rajappa S, Raghunadharao D et al. Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis. Asian Pacific Journal of Cancer Prevention. 2012; 13(10): 4889-95. doi: 10.7314/APJCP.2012.13.10.4889. DOI: https://doi.org/10.7314/APJCP.2012.13.10.4889

Arora N, Manipadam MT, Nair S. Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5115 cases using the World Health Organization 2008 classification and comparison with world literature. Leukemia & lymphoma. 2013 May; 54(5): 1004-11. doi: 10.3109/10428194.2012.729056. DOI: https://doi.org/10.3109/10428194.2012.729056

Sharma M, Mannan R, Madhukar M, Navani S, Manjari M, Bhasin TS et al. Immunohistochemical (IHC) analysis of Non-Hodgkin’s lymphoma (NHL) spectrum according to WHO/REAL classification: A single centre experience from Punjab, India. Journal of clinical and diagnostic research. 2014 Jan; 8(1): 46. doi: 10.7860/JCDR/2014/8173.3988. DOI: https://doi.org/10.7860/JCDR/2014/8173.3988

Dwivedi A, Mehta A, Solanki P. Evaluation of immunohistochemical subtypes in diffuse large B-cell lymphoma and its impact on survival. Indian Journal of Pathology and Microbiology. 2015 Oct; 58(4): 453-8. doi: 10.4103/0377-4929.168886. DOI: https://doi.org/10.4103/0377-4929.168886

Wu D, Wood BL, Fromm JR. Flow cytometry for non-Hodgkin and classical Hodgkin lymphoma. Lymphoma: Methods and Protocols. 2013: 27-47. doi: 10.1007/978-1-62703-269-8_2. DOI: https://doi.org/10.1007/978-1-62703-269-8_2

Wu D, Thomas A, Fromm JR. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte‐rich large B cell lymphoma. Cytometry Part B: Clinical Cytometry. 2016 Sep; 90(5): 424-32. doi: 10.1002/cyto.b.21261. DOI: https://doi.org/10.1002/cyto.b.21261

Chan A, Scarpa Carniello JV, Gao Q, Sigler A, Baik J, Roshal M et al. Role of flow cytometric immunophenotyping for classic Hodgkin lymphoma in small biopsy and cytology specimens. Archives of Pathology & Laboratory Medicine. 2022 Apr; 146(4): 462-8. doi: 10.5858/arpa.2020-0795-OA. DOI: https://doi.org/10.5858/arpa.2020-0795-OA

Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Archives of Pathology & Laboratory Medicine. 2008 Mar; 132(3): 441-61. doi: 10.5858/2008-132-441-AOIITD. DOI: https://doi.org/10.5858/2008-132-441-AOIITD

Singh R, Shaik S, Negi BS, Rajguru JP, Patil PB, Parihar AS et al. Non-Hodgkin's lymphoma: A review. Journal of Family Medicine and Primary Care. 2020 Apr; 9(4): 1834-40. doi: 10.4103/jfmpc.jfmpc_1037_19. DOI: https://doi.org/10.4103/jfmpc.jfmpc_1037_19

Das DK. Contribution of immunocytochemistry to the diagnosis of usual and unusual lymphoma cases. Journal of Cytology. 2018 Jul; 35(3): 163-9. doi: 10.4103/JOC.JOC_42_18. DOI: https://doi.org/10.4103/JOC.JOC_42_18

Cho J. Basic immunohistochemistry for lymphoma diagnosis. Blood Research. 2022 Apr; 57(S1): 55-61. doi: 10.5045/br.2022.2022037. DOI: https://doi.org/10.5045/br.2022.2022037

Borgohain M, Krishnatreya K, Weingken CK, Das JK. Diagnostic Utility of Immunohistochemistry in Lymphoma. International Journal of Contemporary Medical Research. 2017; 4(12): 6-9.